The ATP1A1 gene gives instructions for part of the sodium-potassium pump, a protein that moves sodium out of cells and potassium in to keep nerves, muscles, and other tissues working normally. This gene helps your body maintain electrical signals and fluid balance. If it does not work properly, cells can become less stable, which may contribute to seizures, movement problems, weakness, or low magnesium levels in some people. Rare harmful variants can cause inherited neurologic or kidney conditions.
What is a gene?
Genes are sections of DNA that hold instructions cells use to make molecules or to regulate processes in the body. Some genes provide the code for proteins, which are the parts of cells that do much of the work. Others are mainly involved in controlling when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body grows and works, and they can also influence how you respond to food, stress, and medicines. For a deeper look at this topic, more information is available in the LearnHub.
Overview
ATP1A1Gene function
What if the gene works
The ATP1A1 gene helps cells move sodium out and potassium in. This supports fluid balance and the electrical signals that let nerves and muscles work normally.
Risk
What if the gene does not work
Milder or more severe variants can weaken the cell's sodium-potassium pump. Inherited variants in the ATP1A1 gene are linked to peripheral neuropathy and sometimes developmental delay or seizures, while somatic variants can cause some aldosterone-producing adrenal tumors.
Treatment
What does that mean for your treatment
No ATP1A1-specific treatment or drug choice approach is currently established. Care is usually based on a person’s symptoms and the condition involved, rather than on the ATP1A1 variant itself. In research, the ATP1A1 gene is being studied as a disease driver and possible drug target in some adrenal tumors, but this has not led to guideline-based treatment choices yet.
Conditions associated with ATP1A1
Genetic variants
What if the gene does not work
Variants in the ATP1A1 gene can change the pump protein’s shape, reduce its stability, or keep it from reaching the cell surface, so sodium and potassium movement across the membrane becomes less controlled. Some ATP1A1 gene variants mainly lower activity, while more disruptive variants can nearly shut down the protein. In conditions linked to the ATP1A1 gene, this difference in how much function is lost may be associated with symptoms starting earlier or involving more features.
How variants are linked to conditions
Well-established ATP1A1 gene variants linked to conditions include inherited nerve conditions such as Charcot-Marie-Tooth disease. Other pathogenic variants in the ATP1A1 gene can cause low magnesium levels with kidney problems, and some people also have seizures or learning and development differences. Separate non-inherited ATP1A1 variants found in adrenal tumors are associated with primary aldosteronism, a hormone-related cause of high blood pressure.
A variant is not necessarily a diagnosis
Gene variants are a normal feature of human biology and are common throughout the general population. Most have no direct impact on health and simply represent natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors are involved. In some situations, though, a single well characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the ATP1A1 gene. In most cases, the main factor is whether a disease-causing change in ATP1A1 is present, while symptoms and severity can still vary from one person to another.
Inheritance of ATP1A1 variants
For families trying to understand how ATP1A1 gene variants are inherited, the well-established pattern for ATP1A1-related inherited conditions is autosomal dominant. This means a person with a disease-causing variant in one copy of the ATP1A1 gene can pass it to a child with a 50% chance in each pregnancy. Some people have the variant for the first time because of a new, de novo change, so it was not inherited from either parent.
What does my ATP1A1 result mean for my family?
For ATP1A1, the best-established inherited conditions are usually passed down in a dominant way, so close relatives such as a parent, brother, sister, or child may also carry the same gene change. This can matter if family members have nerve problems, muscle weakness, low magnesium, or related symptoms, even if their symptoms are milder. Each child of someone with a disease-causing ATP1A1 variant has a 1 in 2 chance of inheriting it.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for ATP1A1 variants usually uses DNA from a blood sample, saliva, or a cheek swab. A lab reads the ATP1A1 gene to look for spelling changes in the DNA and compares them with known benign variants or variants linked to health conditions. Results may show a variant is present, absent, or of uncertain significance.
When should I consider getting a genetic test?
Genetic testing for the ATP1A1 gene may be worth considering if you or your child has an unexplained inherited nerve condition, such as early foot drop, hand weakness, balance problems, or numbness, especially when it runs in the family. It can also be considered with repeated very low magnesium levels, seizures, or developmental delay without a clear cause.
A genetic result is only one part of your health story
Genetic findings can provide useful information, but how much they explain varies depending on the condition and the specific variant. Over time, the way your body works is also influenced by factors such as age, medical history, environment, and lifestyle. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is most helpful when considered alongside other parts of care. In other situations, a genetic result can provide a clear answer. In areas such as medication response, genetic results may also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. This helps explain why the same medication may work well for one person, cause more side effects in another, or seem less effective for someone else. Differences in how the body absorbs, breaks down, transports, or responds to a drug are common, and they can influence both benefit and sensitivity to treatment.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect the way they respond to medicines. By studying links between genes and drugs, it helps explain why the same treatment can work differently in different people. With many medications, genes influence both how much effect a drug has and how the body handles it. That information can support treatment decisions that are more informed and more tailored to the individual. More detail on this topic is available in the LearnHub.
Drugs influenced by the ATP1A1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are used, so questions about treatment, side effects, or new symptoms are best discussed with your doctor.
History
Research on the ATP1A1 gene grew out of landmark work on the sodium potassium pump, a discovery that transformed cell biology and later earned a Nobel Prize. In the 1980s, scientists isolated and sequenced ATP1A1 as the gene for one of the pump’s main alpha subunits, giving researchers a direct way to study this essential system in human cells. From these first observations, research expanded steadily. ATP1A1 soon became a standard reference gene in laboratory studies because it is active in many tissues and helped scientists compare related pump genes across the body. More recently, rare ATP1A1 variants have drawn clinical attention after being linked to specific neurologic and endocrine conditions, adding a medical chapter to a gene first known mainly through basic science.